WO2008015429A3 - Composés pharmaceutiques - Google Patents
Composés pharmaceutiques Download PDFInfo
- Publication number
- WO2008015429A3 WO2008015429A3 PCT/GB2007/002926 GB2007002926W WO2008015429A3 WO 2008015429 A3 WO2008015429 A3 WO 2008015429A3 GB 2007002926 W GB2007002926 W GB 2007002926W WO 2008015429 A3 WO2008015429 A3 WO 2008015429A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical compounds
- formula
- conh2
- tautomer
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
- C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne un composé de formule (I) ou un sel, solvate ou tautomère de celui-ci, présentant une activité inhibitrice de PARP. Dans la formule (I) Q est CN ou CONH2 et est lié soit à la position 'a' ou à la position 'b' sur le même noyau benzène; Y1 est N ou N+-O-; Y2 est N ou CR3; Y3 est N ou N+-O-; à condition que lorsque Y2 est CR3, alors Y3 est N+-O-; m est 0, 1 or 2; et R1 et R2 sont tels que définis dans les revendications.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82103106P | 2006-08-01 | 2006-08-01 | |
GB0615299.5 | 2006-08-01 | ||
GB0615299A GB0615299D0 (en) | 2006-08-01 | 2006-08-01 | Pharmaceutical compounds |
US60/821,031 | 2006-08-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008015429A2 WO2008015429A2 (fr) | 2008-02-07 |
WO2008015429A3 true WO2008015429A3 (fr) | 2008-10-02 |
Family
ID=38692040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/002926 WO2008015429A2 (fr) | 2006-08-01 | 2007-08-01 | Composés pharmaceutiques |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008015429A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108138177B9 (zh) | 2015-07-23 | 2021-08-13 | 法国居里学院 | Dbait分子与PARP抑制剂的组合用于治疗癌症的用途 |
WO2018162439A1 (fr) | 2017-03-08 | 2018-09-13 | Onxeo | Nouveau biomarqueur prédictif de la sensibilité à un traitement du cancer avec une molécule dbait |
US20200407720A1 (en) | 2018-03-13 | 2020-12-31 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
WO2021148581A1 (fr) | 2020-01-22 | 2021-07-29 | Onxeo | Nouvelle molécule dbait et son utilisation |
WO2023019912A1 (fr) * | 2021-08-16 | 2023-02-23 | 杭州瑞臻医药有限公司 | Dioxyde de benzotriazine et composition pharmaceutique associée |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007959A1 (fr) * | 2001-07-16 | 2003-01-30 | Fujisawa Pharmaceutical Co., Ltd. | Derives de quinoxaline ayant une action inhibitrice sur parp |
WO2003062234A1 (fr) * | 2002-01-23 | 2003-07-31 | Yamanouchi Pharmaceutical Co., Ltd. | Composes de quinoxaline |
EP1468688A2 (fr) * | 2003-03-14 | 2004-10-20 | Auckland Uniservices Limited | Composées contenants des derivées du N-monooxyde de benzoazin et du 1,4-dioxyde de benzoazin pour le traitement du cancère |
-
2007
- 2007-08-01 WO PCT/GB2007/002926 patent/WO2008015429A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003007959A1 (fr) * | 2001-07-16 | 2003-01-30 | Fujisawa Pharmaceutical Co., Ltd. | Derives de quinoxaline ayant une action inhibitrice sur parp |
WO2003062234A1 (fr) * | 2002-01-23 | 2003-07-31 | Yamanouchi Pharmaceutical Co., Ltd. | Composes de quinoxaline |
EP1468688A2 (fr) * | 2003-03-14 | 2004-10-20 | Auckland Uniservices Limited | Composées contenants des derivées du N-monooxyde de benzoazin et du 1,4-dioxyde de benzoazin pour le traitement du cancère |
Non-Patent Citations (4)
Title |
---|
FUCHS T ET AL: "3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine)", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 66, no. 1, 8 December 2000 (2000-12-08), pages 107 - 114, XP002407530, ISSN: 0022-3263 * |
GIBSON K H ET AL: "Epidermal growth factor receptor tyrosine kinase: structure-activity relationships and antitumour activity of novel quinazolines", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 7, no. 21, 4 November 1997 (1997-11-04), pages 2723 - 2728, XP004136520, ISSN: 0960-894X * |
HAY M P ET AL: "Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 46, no. 1, 2 December 2002 (2002-12-02), pages 169 - 182, XP002404330, ISSN: 0022-2623 * |
HWANG JAE-TAEG ET AL: "Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: The drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 38, no. 43, 26 October 1999 (1999-10-26), pages 14248 - 14255, XP002407531, ISSN: 0006-2960 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008015429A2 (fr) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1889842A4 (fr) | Composé hétérocyclique | |
WO2006038116A3 (fr) | Agents antibacteriens | |
WO2006053255A3 (fr) | Nouveaux derives de betuline, preparation de ces derives et utilisation de ces derives | |
WO2007014054A3 (fr) | Inhibiteur benzenesulfonamide de recepteur de chimiokine ccr2 | |
WO2008109177A3 (fr) | Inhibiteurs de métalloprotéase contenant une fraction hétérocyclique | |
WO2007148185A3 (fr) | 3-amino-pyrrolidino-4-lactames substitués | |
WO2005110410A3 (fr) | Inhibiteurs de kinases en tant qu'agents therapeutiques | |
WO2006128184A3 (fr) | Inhibiteurs de metalloprotease heterobicyclique | |
WO2006028958A3 (fr) | Inhibiteurs pyridyles de la signalisation hedgehog | |
WO2006047528A3 (fr) | Pyrazolobenzamides et leurs derives en tant qu'inhibiteurs du facteur xa | |
AU2003257822A1 (en) | Heterocyclic compound having hiv integrase inhibitory activity | |
ME01992B (fr) | Composes diarylhydantoines | |
BRPI0607545A2 (pt) | composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
WO2007030582A3 (fr) | Inhibiteurs d'ikur acycliques | |
UY30118A1 (es) | Compueto amina trisustituido | |
WO2007025307A3 (fr) | Inhibiteurs des serine proteases | |
TW200833370A (en) | Pharmaceutical composition containing low substituted hydroxypropylcellulose | |
EP1704856A4 (fr) | Inhibiteur de proteines de la famille hsp90 | |
WO2009038064A1 (fr) | Dérivé hétérocyclique à activité inhibitrice sur la 11β-hydroxystéroïde déshydrogénase de type i | |
WO2008156094A1 (fr) | Dérivé de pyridazinone et inhibiteur de la pde le contenant comme ingrédient actif | |
TW200728298A (en) | Thiophene compounds and thrombopoietin receptor activators | |
WO2005105096A3 (fr) | Composes heterocycliques fusionnes | |
TW200626145A (en) | Heterocyclic compounds and thrombopoietin receptor activators | |
WO2004014868A8 (fr) | Derives de pyrimidine 2,4-diones, utilises comme inhibiteurs de metalloproteinase matricielle | |
WO2008105526A1 (fr) | Composé macrocyclique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07766409 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07766409 Country of ref document: EP Kind code of ref document: A2 |